GlassScriptPrepare for your visit
Philip Colaizzo
Pediatrics · Jupiter, FL · NPI 1821023334
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$2,243.23
in general payments reported to CMS, 2019-2025 · $637 in 2025
The $637 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Who reported paying
General payments only, top 6 by amount.
- Corium, LLC $375.66
- Supernus Pharmaceuticals, INC. $334.08
- Collegium Pharmaceutical, INC. $288.98
- Takeda Pharmaceuticals U.S.A., INC. $176.88
- Ironshore Pharmaceuticals INC. $172.80
- Adlon Therapeutics L.P. $160.99
Drugs and devices associated with these payments
Jornay Pm Qelbree Azstarys Valtoco Doc Band Vaxneuvance Gardasil 9 Prevnar 20 Bexsero Prevena V.A.C. Veraflo Cleanse Choice Trumenba
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Philip Colaizzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/870261/philip-colaizzo